Melanocortin
PT-141
Also known as Bremelanotide
A melanocortin-receptor agonist studied in central-nervous-system and melanocortin-pathway research.
PT-141 (bremelanotide) is a cyclic heptapeptide analog of alpha-MSH that activates melanocortin receptors (notably MC4R). It is used as a reference standard in melanocortin-pathway and CNS-signaling research.
Common research areas
- MC4R receptor activation
- Melanocortin-pathway signaling
In our catalog
PT-141 10 mg · $55 CAD · ≥99% HPLC
Related compounds
Selected references
- 1. Bremelanotide. , 2012. PMID 34436837
- 2. Targeting the central melanocortin system for the treatment of metabolic disorders. Nat Rev Endocrinol, 2023. PMID 37365323
- 3. Bremelanotide: First Approval. Drugs, 2019. PMID 31429064
For laboratory research use only. Reference information, not usage guidance or dosing advice.